Episurf Medical continues to build its patent portfolio in Japan, announcing that the regional office will grant another patent titled “System and method for creating a decision support material indicating damage to an anatomical joint,” addressing 3D-based assessment of joint lesions.
Previously-granted patents in Japan addressed the company’s individualized Episealer® Femoral Twin joint implant and its design, as well as medical image segmentation used for joint damage visualization and the manufacturing of personalized joint implants and surgical instruments.
“This is a core patent for Episurf’s medical imaging technology, and we are happy to get it approved in strategically selected countries,” said Katarina Flodström, COO.
Episurf Medical continues to build its patent portfolio in Japan, announcing that the regional office will grant another patent titled “System and method for creating a decision support material indicating damage to an anatomical joint,” addressing 3D-based assessment of joint lesions.
Previously-granted patents in Japan addressed the...
Episurf Medical continues to build its patent portfolio in Japan, announcing that the regional office will grant another patent titled “System and method for creating a decision support material indicating damage to an anatomical joint,” addressing 3D-based assessment of joint lesions.
Previously-granted patents in Japan addressed the company’s individualized Episealer® Femoral Twin joint implant and its design, as well as medical image segmentation used for joint damage visualization and the manufacturing of personalized joint implants and surgical instruments.
“This is a core patent for Episurf’s medical imaging technology, and we are happy to get it approved in strategically selected countries,” said Katarina Flodström, COO.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
